Gyre Therapeutics, Inc. GYRE Book value per share

Book value per share at other companies

Eli LillyLLY

$37.91+86.7%

Madrigal Pharmaceuticals, Inc.MDGL

$17.97-42.7%

Viking TherapeuticsVKTX

$4.34-42.5%

Theravance BiopharmaTBPH

$5.61+26.5%

Rigel PharmaceuticalsRIGL

$20.31+1,888%

Zevra Therapeutics, Inc.ZVRA

$3.55+70.5%

FAQ

What is Gyre Therapeutics, Inc.'s book value per share?

Gyre Therapeutics, Inc. (GYRE) reported book value per share of $1.07 in Q2 2026.

How has Gyre Therapeutics, Inc.'s book value per share changed year-over-year?

Gyre Therapeutics, Inc.'s book value per share increased by 4.0% year-over-year, from $1.03 to $1.07.

What is the long-term trend for Gyre Therapeutics, Inc.'s book value per share?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s book value per share has grown at a -31.3% compound annual growth rate (CAGR), from $3.97 to $0.61.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.